Progress against tuberculosis in WHO's South East Asian Region, which includes India, will have a major impact on the advancement globally, a top official of the global health body has said, as member nations today pledged to intensify efforts in ensuring rapid progress to end the disease by 2030.
In a statement adopted at the Delhi End TB Summit here, member countries unanimously agreed for actualising and intensifying essential actions agreed upon in the Delhi Call to Action adopted in March last year, to accelerate efforts to end tuberculosis in the region.
"Progress against TB in this region (South East Asian region) will have a major impact on the progress globally. Too much is at stake, we cannot afford to fail. We must remember that the war against TB will be won in communities.
"It will be won by nurses, doctors, community health workers and others at the frontlines. We must give them the resources they need to find every last person with TB, to diagnose them, to treat them, and to cure them," Tedros Adhanom Ghebreyesus, DG WHO, who participated in the event said.
The Delhi End TB Summit was inaugurated by Prime Minister Narendra Modi yesterday where he announced the target to free India from the disease by 2025 - five years ahead of a global deadline.
WHO said TB was responsible for 1.7 million deaths in 2016, despite most cases being curable and over 10 million people contract the disease every year.
TB is the leading infectious killer in India. There were an estimated 28 lakh new cases of the disease in 2016, with over 4 lakh people succumbing to the disease, including those with TB and HIV.
WHO South-East Asia Region, which hosts about one-fourth of the global population, shares a disproportionate 46 per cent global TB burden.
Welcoming the statement, Poonam Khetrapal Singh, Regional Director for WHO South-East Asia, said, it gives shape to the momentum and aspirations, and does so by setting out a series of strategic priorities.
"(The priorities) include establishing strong leadership of TB programmes at the national level, increasing budgetary and human resource allocations to TB programmes from domestic and global sources, enabling each and every TB patient to access the best possible care available and supplementing medical care for TB with social and financial protection," Singh said.
Reviewing efforts being made to end tuberculosis since the adoption of the Delhi Call for Action on March 16, 2017, member countries noted that though efforts have been strengthened with increased attention, investments and initiatives, the stepped-up response was "falling short" of what was required to reach the critical thresholds for ending TB.
The member countries of the region stressed their firm intent to collectively reach out to two million missing TB cases and 1,50, 000 multidrug-resistance cases by 2020 and implement a response that is demonstrably adequate for ending the disease.
In the statement, the countries committed to multi-sectoral and empowered national initiatives, reporting to the highest levels of government, to lead the TB programme.
"The member countries committed to increasing budgetary and human resource allocations by governments as well as by their global, domestic and other partners so as to ensure that national TB plans are fully funded," WHO said in a statement.
The Delhi End TB Summit was hosted by the Indian Health Ministry, the World Health Organisation and the Stop TB Partnership.
The Stop TB Partnership's Executive Director, Dr Lucica Ditiu, and the Global Fund's Executive Director, Peter Sands, were among the prominent health leaders attending the week-long meeting.
Health ministers of a number of countries including Sri Lanka, Indonesia, Bangladesh, Nigeria, Mozambique, Zimbabwe, Kazakhstan and Peru are also participating.
The summit sets the stage for the September 2018 United Nations High-Level Meeting on TB. For the first time TB will be discussed in the UN General Assembly at the Heads of State level.
The UN high-level meeting is expected to endorse an ambitious set of goals to put the world on course to ending tuberculosis.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
